Pulmonary alveolar proteinosis following cryptococcal meningitis: a possible cause?

Sarah Demir1, Nader Chebib1, Francoise Thivolet-Bejui2

  • 1Department of Pneumology, Hospices Civils de Lyon, National Reference Center for Rare Pulmonary Diseases, Lyon, France.

BMJ Case Reports
|March 30, 2018
PubMed

Insights

Autoimmune pulmonary alveolar proteinosis (PAP) is linked to anti-GM-CSF antibodies. These antibodies may predispose individuals to opportunistic infections like cryptococcal meningitis, even in healthy subjects.

Area of Science:

  • Pulmonology
  • Immunology
  • Infectious Diseases

Background:

  • Autoimmune pulmonary alveolar proteinosis (PAP) is a rare interstitial lung disease associated with autoantibodies against granulocyte-macrophage colony-stimulating factor (GM-CSF).
  • GM-CSF autoantibodies are implicated in the pathogenesis of PAP by impairing monocyte and macrophage phagocytic function.

Observation:

  • A patient presented with cryptococcal meningitis and a pulmonary mass, later developing bilateral ground glass opacities and a crazy paving pattern on CT.
  • Diagnosis of PAP was confirmed via biopsy showing proteinaceous alveolar deposits and high serum anti-GM-CSF antibody titers.
  • Radiological lesions of PAP showed progressive decrease without specific treatment after cryptococcal infection control.

Findings:

  • The case highlights a potential association between autoimmune PAP, anti-GM-CSF antibodies, and opportunistic infections, specifically cryptococcosis.
  • The presence of anti-GM-CSF antibodies may compromise immune defenses, increasing susceptibility to infections in individuals without pre-existing conditions.

Implications:

  • This suggests that anti-GM-CSF antibodies might play a broader role in immune dysregulation, potentially leading to opportunistic infections.
  • Further research is warranted to elucidate the precise mechanisms linking anti-GM-CSF antibodies to increased susceptibility to infections and the management of such cases.

Related Concept Videos

Cranial and Spinal Meninges01:19

Cranial and Spinal Meninges

The cranial and spinal meninges are complex protective structures surrounding the central nervous system (CNS), consisting of the brain and spinal cord. These meninges consist of the dura mater, the arachnoid mater, and the pia mater. They protect the CNS, provide structural support, and aid in circulating cerebrospinal fluid (CSF).
Cranial Meninges
These meningeal layers cover the cranium. The dura mater is the outermost layer of cranial meninges. It is a thick and durable membrane of dense...
4.1K
Alveoli and Alveolar Ducts01:26

Alveoli and Alveolar Ducts

The respiratory zone of the human body, which stands in contrast to the conducting zone, comprises the structures that actively participate in the exchange of gases. The initiation of this zone is marked by the terminal bronchioles converging into respiratory bronchioles, the tiniest bronchiole classification. The respiratory bronchioles give way to the alveolar ducts that opens into a congregation of alveoli. Actively involved in gas exchange, alveoli resemble tiny sacs similar to clusters of...
6.0K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.0K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.6K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
651